SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-003208
Filing Date
2021-01-29
Accepted
2021-01-29 07:03:29
Documents
14
Period of Report
2021-01-29
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ortx-8k_20210129.htm   iXBRL 8-K 41589
2 EX-99.1 ortx-ex991_6.htm EX-99.1 22582
3 GRAPHIC gwjqumnbumzd000001.jpg GRAPHIC 8149
  Complete submission text file 0001564590-21-003208.txt   207956

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ortx-20210129.xsd EX-101.SCH 5784
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ortx-20210129_lab.xml EX-101.LAB 18653
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ortx-20210129_pre.xml EX-101.PRE 11159
7 EXTRACTED XBRL INSTANCE DOCUMENT ortx-8k_20210129_htm.xml XML 3472
Mailing Address 108 CANNON STREET LONDON X0 EC4N 6EU
Business Address 108 CANNON STREET LONDON X0 EC4N 6EU 011-44-0-203-3846700
Orchard Therapeutics plc (Filer) CIK: 0001748907 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38722 | Film No.: 21568070
SIC: 2836 Biological Products, (No Diagnostic Substances)